When probing the effects of Nod1-mediated dysglycemia, our model demonstrates that activation of Nod1 lowers fasting blood glucose coincident with significant glucose intolerance (i.e. increase in blood glucose levels in response to glucose challenge). This evidence concerns the gene NOD1 and Glucose intolerance.